Docoh
Loading...

CDNA Caredx

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.

Company profile

Ticker
CDNA
Exchange
Website
CEO
Peter Maag
Employees
Incorporated
Location
Fiscal year end
Former names
EXPRESSION DIAGNOSTICS INC, XDx, Inc.
SEC CIK
Subsidiaries
CareDx International AB • CareDx AB • CareDx Lab Solutions, Inc. • CareDx Transplant Management, Inc. • CareDx GmbH • CareDx Pty Ltd. ...

CDNA stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

29 Jul 21
20 Oct 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Caredx earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 335.89M 335.89M 335.89M 335.89M 335.89M 335.89M
Cash burn (monthly) (positive/no burn) (positive/no burn) 1.58M 1.04M (positive/no burn) 954.5K
Cash used (since last report) n/a n/a 5.84M 3.83M n/a 3.53M
Cash remaining n/a n/a 330.05M 332.07M n/a 332.37M
Runway (months of cash) n/a n/a 208.8 320.6 n/a 348.2

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
11 Oct 21 Goldberg Michael Common Stock Sell Dispose S No Yes 62.502 500 31.25K 60,568
11 Oct 21 Goldberg Michael Common Stock Option exercise Acquire M No Yes 1.22 500 610 61,068
11 Oct 21 Goldberg Michael Stock Option Common Stock Option exercise Dispose M No Yes 1.22 500 610 14,500
5 Oct 21 Peter Maag Common Stock Sell Dispose S No Yes 65.9026 1,163 76.64K 341,756
5 Oct 21 Peter Maag Common Stock Sell Dispose S No Yes 64.9467 3,612 234.59K 342,919
5 Oct 21 Peter Maag Common Stock Sell Dispose S No Yes 64.211 5,225 335.5K 346,531
5 Oct 21 Peter Maag Common Stock Option exercise Acquire M No Yes 24.35 5,347 130.2K 351,756
5 Oct 21 Peter Maag Common Stock Option exercise Acquire M No Yes 12.24 3,727 45.62K 346,409
5 Oct 21 Peter Maag Common Stock Option exercise Acquire M No Yes 6.31 926 5.84K 342,682
5 Oct 21 Peter Maag Employee Stock Option Common Stock Option exercise Dispose M No Yes 24.35 5,347 130.2K 56,906

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 253 244 +3.7%
Opened positions 48 47 +2.1%
Closed positions 39 37 +5.4%
Increased positions 72 74 -2.7%
Reduced positions 103 93 +10.8%
13F shares
Current Prev Q Change
Total value 5.43B 4.73B +15.0%
Total shares 60.34M 59.28M +1.8%
Total puts 524.8K 539K -2.6%
Total calls 308.3K 246.1K +25.3%
Total put/call ratio 1.7 2.2 -22.3%
Largest owners
Shares Value Change
Alger Associates 5.35M $387.89M 0.0%
Vanguard 5.24M $479.22M +4.7%
ARK Investment Management 4.56M $417.71M +2.3%
BLK Blackrock 4.23M $386.89M +3.1%
Fred Alger Management 3.43M $313.55M -16.6%
IVZ Invesco 2.96M $270.84M -1.5%
Matrix Capital Management 1.74M $159.23M +20.9%
Clearbridge Advisors 1.65M $151.33M +9.6%
Midroc Invest AB 1.6M $17.85M 0.0%
STT State Street 1.49M $135.91M -10.8%
Largest transactions
Shares Bought/sold Change
WDR Waddell & Reed Financial 0 -1.53M EXIT
MCQEF Macquarie 1.44M +1.44M +62172.0%
Fred Alger Management 3.43M -680.34K -16.6%
Millennium Management 544.16K +490.55K +915.1%
MS Morgan Stanley 500.54K +362.77K +263.3%
CMTDF Sumitomo Mitsui Trust 1.18M +356.86K +43.5%
Nikko Asset Management Americas 1.17M +352.6K +43.2%
Two Sigma Investments 41.8K -348.28K -89.3%
Conestoga Capital Advisors 348.19K +348.19K NEW
ArrowMark Colorado 637.56K +327.7K +105.8%

Financial report summary

?
Competition
IlluminaNatera
Risks
  • Our business may be adversely affected by the effects of health epidemics, including the recent coronavirus outbreak.
  • We have a history of losses, and we expect to incur net losses for the next several years.
  • We may require additional financing.
  • If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.
  • Our portfolio of marketable securities is significant and subject to market, interest and credit risk that may reduce its value.
  • Our competitive position depends on maintaining intellectual property protection.
  • Our operating results may fluctuate, which could cause our stock price to decrease.
  • The market price of our common stock has been and will likely continue to be volatile, and you could lose all or part of your investment.
Management Discussion
  • ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
  • This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements.  The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “should,” “would,” “project,” “plan,” “target,” “contemplate,” “predict,” “expect” and the negative and plural forms of these words and similar expressions are intended to identify forward-looking statements.
  • •our ability to comply with the requirements of being a public company.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: administered, Alex, alternative, Alternatively, ANKUR, assay, biotechnology, bring, call, choosing, clarify, compensatory, complaint, composite, consent, consented, DHINGRA, discourage, duly, economy, efficacy, eliminate, engineered, eventually, Exhibit, external, forum, freely, freestanding, Furnished, half, herewith, Hero, higher, implantable, inapplicable, inline, innovation, Instance, interactive, issuer, Johnson, judicial, jurisdiction, KOAR, Label, lifted, Linkbase, logging, Miromatrix, move, nephrology, OrganX, Page, post, prolonged, Promotion, provision, pursuit, REGINALD, registrant, restated, SC, Schema, scoring, SEETO, selection, stockholder, survival, Taxonomy, thereunder, thereunto, undersigned, vaccine, virtual, waiting, waive, writing, written, XBRL
Removed: consulting, modified, online, released, telephone, updated